-
1
-
-
79951804452
-
Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
-
Kim DI, Im MS, Choi JH, et al. Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients. Korean J Pediatr. 2010;53:1000-1005.
-
(2010)
Korean J Pediatr.
, vol.53
, pp. 1000-1005
-
-
Kim, D.I.1
Im, M.S.2
Choi, J.H.3
-
2
-
-
80052188407
-
Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations
-
Frymoyer A, Guglielmo BJ, Wilson SD, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011;31:871-876.
-
(2011)
Pharmacotherapy
, vol.31
, pp. 871-876
-
-
Frymoyer, A.1
Guglielmo, B.J.2
Wilson, S.D.3
-
3
-
-
79951821210
-
Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: Executive summary
-
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285-292.
-
(2011)
Clin Infect Dis.
, vol.52
, pp. 285-292
-
-
Liu, C.1
Bayer, A.2
Cosgrove, S.E.3
-
4
-
-
70350510606
-
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
-
Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29:1275-1279.
-
(2009)
Pharmacotherapy
, vol.29
, pp. 1275-1279
-
-
Rybak, M.J.1
Lomaestro, B.M.2
Rotschafer, J.C.3
-
5
-
-
67649543995
-
Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate
-
Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009;28:398-402.
-
(2009)
Pediatr Infect Dis J.
, vol.28
, pp. 398-402
-
-
Frymoyer, A.1
Hersh, A.L.2
Benet, L.Z.3
-
6
-
-
77951899851
-
Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation
-
Frymoyer A, Hersh AL, Coralic Z, et al. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther. 2010;32:534-542.
-
(2010)
Clin Ther.
, vol.32
, pp. 534-542
-
-
Frymoyer, A.1
Hersh, A.L.2
Coralic, Z.3
-
7
-
-
84891836161
-
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections
-
Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013;32:1077-1079.
-
(2013)
Pediatr Infect Dis J.
, vol.32
, pp. 1077-1079
-
-
Frymoyer, A.1
Guglielmo, B.J.2
Hersh, A.L.3
-
8
-
-
84876295339
-
Improved vancomycin dosing in children using area under the curve exposure
-
Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013;32:e155-e163.
-
(2013)
Pediatr Infect Dis J.
, vol.32
, pp. e155-e163
-
-
Le, J.1
Bradley, J.S.2
Murray, W.3
-
9
-
-
77950208675
-
Should higher vancomycin trough levels be targeted for invasive community-acquired methicillinresistant Staphylococcus aureus infections in children?
-
Jimenez-Truque N, Thomsen I, Saye E, et al. Should higher vancomycin trough levels be targeted for invasive community-acquired methicillinresistant Staphylococcus aureus infections in children? Pediatr Infect Dis J. 2010;29:368-370.
-
(2010)
Pediatr Infect Dis J.
, vol.29
, pp. 368-370
-
-
Jimenez-Truque, N.1
Thomsen, I.2
Saye, E.3
-
10
-
-
77749255891
-
Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin
-
Welsh KJ, Abbott AN, Lewis EM, et al. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. J Clin Microbiol. 2010;48:894-899.
-
(2010)
J Clin Microbiol.
, vol.48
, pp. 894-899
-
-
Welsh, K.J.1
Abbott, A.N.2
Lewis, E.M.3
-
11
-
-
79953907324
-
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: Support for consensus guidelines suggested targets
-
Kullar R, Davis SL, Levine DP, et al. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52:975-981.
-
(2011)
Clin Infect Dis.
, vol.52
, pp. 975-981
-
-
Kullar, R.1
Davis, S.L.2
Levine, D.P.3
-
12
-
-
84879585901
-
Acute kidney injury during vancomycin therapy in critically ill children
-
Totapally BR, Machado J, Lee H, et al. Acute kidney injury during vancomycin therapy in critically ill children. Pharmacotherapy. 2013;33:598-602.
-
(2013)
Pharmacotherapy.
, vol.33
, pp. 598-602
-
-
Totapally, B.R.1
Machado, J.2
Lee, H.3
-
13
-
-
79951579705
-
Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children
-
McKamy S, Hernandez E, Jahng M, et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr. 2011;158:422-426.
-
(2011)
J Pediatr.
, vol.158
, pp. 422-426
-
-
McKamy, S.1
Hernandez, E.2
Jahng, M.3
-
14
-
-
0033958126
-
A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population
-
Lamarre P, Lebel D, Ducharme MP. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrob Agents Chemother. 2000;44:278-282.
-
(2000)
Antimicrob Agents Chemother.
, vol.44
, pp. 278-282
-
-
Lamarre, P.1
Lebel, D.2
Ducharme, M.P.3
-
15
-
-
84941895997
-
Validation of a pediatric population pharmakokinetic model for vancomycin
-
Nov. 21 Epub ahead of print
-
Hahn A, Frenck RW, Zou Y, et al. Validation of a pediatric population pharmakokinetic model for vancomycin. Ther Drug Monit. 2014 Nov. 21 [Epub ahead of print].
-
(2014)
Ther Drug Monit.
-
-
Hahn, A.1
Frenck, R.W.2
Zou, Y.3
-
16
-
-
84941916894
-
Low sensitivity of discharge diagnostic codes for Staphylococcus aureus bloodstream infections at a large pediatric hospital
-
April 29, Boston, MA
-
Kreppel A, Rice M, Back N, et al. Low sensitivity of discharge diagnostic codes for Staphylococcus aureus bloodstream infections at a large pediatric hospital. Presented at the Pediatic Academic Society Meeting; April 29, 2012; Boston, MA.
-
(2012)
The Pediatic Academic Society Meeting
-
-
Kreppel, A.1
Rice, M.2
Back, N.3
-
17
-
-
0026580927
-
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
-
Proost JH, Meijer DK. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med. 1992;22:155-163.
-
(1992)
Comput Biol Med.
, vol.22
, pp. 155-163
-
-
Proost, J.H.1
Meijer, D.K.2
-
18
-
-
0031985373
-
Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, Bayesian feedback and individualised target goals
-
Jelliffe RW, Schumitzky A, Bayard D, et al. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, Bayesian feedback and individualised target goals. Clin Pharmacokinet. 1998;34:57-77.
-
(1998)
Clin Pharmacokinet.
, vol.34
, pp. 57-77
-
-
Jelliffe, R.W.1
Schumitzky, A.2
Bayard, D.3
-
19
-
-
84888642447
-
Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive Staphylococcal infections
-
Chhim RF, Arnold SR, Lee KR. Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive Staphylococcal infections. J Pediatr Infect Dis Soc. 2013;2:259-262.
-
(2013)
J Pediatr Infect Dis Soc.
, vol.2
, pp. 259-262
-
-
Chhim, R.F.1
Arnold, S.R.2
Lee, K.R.3
-
20
-
-
84862965924
-
Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization
-
Brown J, Brown K, Forrest A. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother. 2012;56:634-638.
-
(2012)
Antimicrob Agents Chemother.
, vol.56
, pp. 634-638
-
-
Brown, J.1
Brown, K.2
Forrest, A.3
-
21
-
-
84875183210
-
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
-
Holmes NE, Turnidge JD, Munckhof WJ, et al. Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2013;57:1654-1663.
-
(2013)
Antimicrob Agents Chemother.
, vol.57
, pp. 1654-1663
-
-
Holmes, N.E.1
Turnidge, J.D.2
Munckhof, W.J.3
-
22
-
-
84879435833
-
A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
-
Gawronski KM, Goff DA, Brown J, et al. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Clin Ther. 2013;35:772-779.
-
(2013)
Clin Ther.
, vol.35
, pp. 772-779
-
-
Gawronski, K.M.1
Goff, D.A.2
Brown, J.3
-
23
-
-
84872925796
-
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureusassociated septic shock
-
Zelenitsky S, Rubinstein E, Ariano R, et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureusassociated septic shock. Int J Antimicrobi Agents. 2013;41:255-260.
-
(2013)
Int J Antimicrobi Agents.
, vol.41
, pp. 255-260
-
-
Zelenitsky, S.1
Rubinstein, E.2
Ariano, R.3
-
24
-
-
0029145482
-
Influence of malignancy on the pharmacokinetics of vancomycin in infants and children
-
Chang D. Influence of malignancy on the pharmacokinetics of vancomycin in infants and children. Pediatr Infect Dis J. 1995;14:667-673.
-
(1995)
Pediatr Infect Dis J.
, vol.14
, pp. 667-673
-
-
Chang, D.1
-
25
-
-
80052895223
-
Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: Methodology correlations, temporal trends and clonal patterns
-
van Hal SJ, Barbagiannakos T, Jones M, et al. Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. J Antimicrob Chemother. 2011;66:2284-2287.
-
(2011)
J Antimicrob Chemother.
, vol.66
, pp. 2284-2287
-
-
Van Hal, S.J.1
Barbagiannakos, T.2
Jones, M.3
|